This week the Food and Drug Administration fully approved the first-ever Alzheimer’s treatment. Called Leqembi, the drug has been clinically proven to effectively slow the early progression of Alzheimer’s disease. Leqembi is not without controversy; some doctors have pointed to life-threatening side effects like chronic headaches, brain hemorrhages and bleeds from the drug.

Don’t forget to SUBSCRIBE for daily videos: [ Ссылка ]
**More info & videos below**

For full episodes, check out [ Ссылка ]

Let us know what you think!
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]

-----------------

While NJ PBS does not and cannot review every submission and is not responsible for the content of your comments, NJTV reserves the right to delete, remove, move, or edit comments that it, in its sole discretion, deems abusive, defamatory, obscene, or otherwise inappropriate or unacceptable for any reason.

-----------------

NJ Spotlight News with Briana Vannozzi is a week-nightly news program on NJ PBS covering local New Jersey news as well as a multi-platform, local information source for New Jersey.

Be sure to share with us your story ideas, feedback and tips about news in your neighborhood here: [ Ссылка ]

NJ Spotlight News with Briana Vannozzi airs every weeknight at 6, 7:30 and 11 p.m. ET on NJ PBS.

свернуть